Abstract
Gene therapy using RNA interference can be directed against tumors through various strategies, but has been hindered owing to the inefficiency of non-viral delivery. To evaluate the antitumor effects of adenine nucleotide translocase-2 (ANT2) short hairpin RNA (shRNA) by intraperitoneal injection using the polyethylenimine (PEI) and an ultrasound gene delivery method, human breast carcinoma MDA-MB-231 cells were injected subcutaneously into NOG (NOD/Shi-scid/IL-2RĪ³null) mice. The results showed greater tumor regression (*P<0.05) as well as an increased survival rate in the group receiving ANT2 shRNA+two types of enhancer relative to the groups receiving ANT2 shRNA without enhancer. These findings demonstrate that the introduction of PEI and ultrasound with SonoVue exerted enhanced antitumor effects in vivo. Although the combination of jet-PEI and ultrasound provided the best results with respect to tumor regression, the antitumor effects from the individual enhancers were approximately equivalent. In addition, we confirmed that there was no toxicity on aspartate aminotransferase and alanine aminotransferase levels in the liver and albumin, blood urea nitrogen or creatine kinase levels in the kidney following the various gene delivery methods.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lin C-R, Chen K-H, Yang C-H, Cheng J-T, Sheen-Chen S-M, Wu C-H et al. Sonoporation-mediated gene transfer into adult rat dorsal root ganglion cells. J Biomed Sci 2010; 17: 44.
Bekeredjian R, Grayburn PA, Shohet RV . Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 2005; 45: 329ā335.
Shen Z-Y, Hu B . Low-frequency low-intensity ultrasound with contrast agent for the treatment of subcutaneous tumors in mice. Sci Res Essays 2011; 6: 5579ā5585.
Zhang L, Yang N, Mohamed-Hadley A, Rubin SC, Coukos G . Vector-based RNAi a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer. Biochem Biophys Res Commun 2003; 303: 1169ā1178.
Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A . RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Therapy 2005; 12: 461ā466.
Jang J-Y, Choi Y, Jeon Y-K, Kim C-W . Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo. Breast Cancer Res 2008; 10: R11.
Jang J-Y, Jeon Y-K, Kim C-W . Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells. BMC Cancer 2010; 10: 391.
Choi Y, Jeon YH, Jang J-Y, Chung J-K, Kim C-W . Treatment With mANT2 shRNA enhances antitumor therapeutic effects induced by MUC1 DNA vaccination. Mol Ther 2011; 19: 979ā989.
JƤnicke RU . MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Treat 2009; 117: 219ā221.
Doerner A, Pauschinger M, Badorff A, Noutsias M, Giessen S, Schulze K et al. Tissue-specific transcription pattern of the adenine nucleotide translocase isoforms in humans. FEBS Lett 1997; 414: 258ā262.
Luciakova K, Barath P, Poliakova D, Persson A, Nelson BD . Repression of the human adenine nucleotide translocase-2 gene in growth-arrested human diploid cells the role of nuclear factor-1. J Biol Chem 2003; 278: 30624ā30633.
Miller DL, Pislaru SV, Greenleaf JF . Sonoporation: mechanical DNA delivery by ultrasonic cavitation. Somatic Cell Mol Genet 2002; 27: 115ā134.
Thomas M, Klibanov A . Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol 2003; 62: 27ā34.
Zhang Y, Satterlee A, Huang L . In vivo gene delivery by nonviral vectors: overcoming hurdles & quest. Mol Ther 2012; 20: 1298ā1304.
Li S, Huang L . Nonviral gene therapy: promises and challenges. Gene Therapy 2000; 7: 31ā34.
Aihara H, Miyazaki J-i . Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867ā870.
Yoshida A, Nagata T, Uchijima M, Higashi T, Koide Y . Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses. Vaccine 2000; 18: 1725ā1729.
Huth S, Lausier J, Gersting SW, Rudolph C, Plank C, Welsch U et al. Insights into the mechanism of magnetofection using PEIābased magnetofectins for gene transfer. J Gene Med 2004; 6: 923ā936.
Newman C, Bettinger T . Gene therapy progress and prospects: ultrasound for gene transfer. Gene Therapy 2007; 14: 465ā475.
Erbacher P, Bettinger T, BelguiseāValladier P, Zou S, Coll JL, Behr JP et al. Transfection and physical properties of various saccharide, poly (ethylene glycol), and antibodyāderivatized polyethylenimines (PEI). J Gene Med 1999; 1: 210ā222.
Aoki K, Furuhata S, Hatanaka K, Maeda M, Remy J, Behr J et al. Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity. Gene Therapy 2001; 8: 504ā514.
Werth S, Urban-Klein B, Dai L, Hƶbel S, Grzelinski M, Bakowsky U et al. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. J Control Rel 2006; 112: 257ā270.
Moret I, Esteban Peris J, Guillem VM, Benet M, Revert F, DasĆ F et al. Stability of PEIāDNA and DOTAPāDNA complexes: effect of alkaline pH, heparin and serum. J Control Rel 2001; 76: 169ā181.
Saito M, Mazda O, Takahashi KA, Arai Y, Kishida T, ShināYa M et al. Sonoporation mediated transduction of pDNA/siRNA into joint synovium in vivo. J Orthop Res 2007; 25: 1308ā1316.
Xenariou S, Griesenbach U, Liang H, Zhu J, Farley R, Somerton L et al. Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Therapy 2007; 14: 768ā774.
Dang S-p, Wang R-x, Qin M-d, Zhang Y, Gu Y-z, Wang M-y et al. A novel transfection method for eukaryotic cells using polyethylenimine coated albumin microbubbles. Plasmid 2011; 66: 19ā25.
Phillips LC, Klibanov AL, Wamhoff BR, Hossack JA . Targeted gene transfection from microbubbles into vascular smooth muscle cells using focused, ultrasound-mediated delivery. Ultrasound Med Biol 2010; 36: 1470ā1480.
Liu J, Lewis TN, Prausnitz MR . Non-invasive assessment and control of ultrasound-mediated membrane permeabilization. Pharm Res 1998; 15: 918ā924.
Wei W, Zheng-zhong B, Yong-jie W, Qing-wu Z, Ya-lin M . Bioeffects of low-frequency ultrasonic gene delivery and safety on cell membrane permeability control. J Ultrasound Med 2004; 23: 1569ā1582.
Zhou Y, Cui J, Deng CX . Dynamics of sonoporation correlated with acoustic cavitation activities. Biophys J 2008; 94: L51āL53.
Aigner A, Fischer D, Merdan T, Brus C, Kissel T, Czubayko F . Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression. Gene Therapy 2002; 9: 1700ā1707.
Intra J, Salem AK . Characterization of the transgene expression generated by branched and linear polyethylenimine-plasmid DNA nanoparticles in vitro and after intraperitoneal injection in vivo. J Control Rel 2008; 130: 129ā138.
Louis M, Dutoit S, Denoux Y, Erbacher P, Deslandes E, Behr J et al. Intraperitoneal linear polyethylenimine (L-PEI)-mediated gene delivery to ovarian carcinoma nodes in mice. Cancer Gene Ther 2006; 13: 367ā374.
Dou S, Smith M, Wang Y, Rusckowski M, Liu G . Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapy. Cancer Biother Radiopharm 2013; 28: 335ā342.
Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297ā7301.
Demeneix B, Behr JP . Polyethylenimine (PEI). Adv Genet 2005; 53: 215ā230.
Williams A . A possible alteration in the permeability of ascites cell membranes after exposure to acoustic microstreaming. J Cell Sci 1973; 12: 875ā885.
Wu J, Nyborg WL . Ultrasound, cavitation bubbles and their interaction with cells. Adv Drug Deliv Rev 2008; 60: 1103ā1116.
Okada K, Kudo N, Niwa K, Yamamoto K . A basic study on sonoporation with microbubbles exposed to pulsed ultrasound. J Med Ultrason 2005; 32: 3ā11.
Forbes MM, Steinberg RL . Examination of inertial cavitation of Optison in producing sonoporation of Chinese hamster ovary cells. Ultrasound Med Biol 2008; 34: 2009ā2018.
Niidome T, Huang L . Gene therapy progress and prospects: nonviral vectors. Gene Therapy 2002; 9: 1647ā1652.
Herweijer H, Wolff J . Progress and prospects: naked DNA gene transfer and therapy. Gene Therapy 2003; 10: 453ā458.
Atici S, Cinel I, Cinel L, Doruk N, Eskandari G, Oral U . Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model. J Biosci 2005; 30: 245ā252.
Zhang L, Liu Y, Xiang G, Lv Q, Huang G, Yang Y et al. Ultrasound-triggered microbubble destruction in combination with cationic lipid microbubbles enhances gene delivery. J Huazhong Univ Sci Technol [Medical Sciences] 2011; 31: 39ā45.
Shen Z, Brayman A, Chen L, Miao C . Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery. Gene Therapy 2008; 15: 1147ā1155.
Ferrara K, Pollard R, Borden M . Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 2007; 9: 415ā447.
Song S, Shen Z, Chen L, Brayman A, Miao C . Explorations of high-intensity therapeutic ultrasound and microbubble-mediated gene delivery in mouse liver. Gene Therapy 2011; 18: 1006ā1014.
Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K et al. NOD/SCID/Ī³ mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 3175ā3182.
Leighton T . The Acoustic Bubble. Academic Press: New York, NY, USA, 1994.
Schneider M . Characteristics of SonoVueā¢. Echocardiography 1999; 16: 743ā746.
Acknowledgements
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT & Future Planning (MSIP) (NRF-2013R1A2A2A04016262), (2012-0001190), (M1AXA003-2011-0032035), and (2010-00757), Republic of Korea.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Park, D., Jung, B., Lee, Y. et al. Evaluation of in vivo antitumor effects of ANT2 shRNA delivered using PEI and ultrasound with microbubbles. Gene Ther 22, 325ā332 (2015). https://doi.org/10.1038/gt.2014.120
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2014.120